Baricitinib in CPPD - the BAPTIST Study

Clinical trial NCT06768294 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06768294
Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Calcium Pyrophosphate Deposition Disease Chondrocalcinosis

Start date: 2025-01-01
Primary completion: 2026-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.